Teva Pharmaceutical IndustriesvsUnitedHealth

TEVA and UNH stock compared: price, dividend, valuation and results, from SEC filings.

TEVA

Teva Pharmaceutical Industries Limited

$42.23

Value $48.6B

-0.92%
TEVA's page

UNH

UnitedHealth Group Incorporated

$349.91

Value $318B

-10.21%
UNH's page

Teva Pharmaceutical Industries (TEVA) has a market value of $48.6B and UnitedHealth (UNH) $318B. Over the last year, with dividends, TEVA moved +71.7% and UNH +12.1%. Dividend yield: TEVA none, UNH 2.59%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TEVA$48.6B

    UNH$318B

    UNH is 6.5 times TEVA

  • Revenue, 12 months

    TEVA$14.0B

    UNH$450B

    UNH is 32 times TEVA

  • Net income, 12 months

    TEVA$507M

    UNH$15.9B

    UNH is 31 times TEVA

  • Operating margin

    TEVA10.2%

    UNH5.3%

    4.9 points apart

  • ROIC

    TEVA10.9%

    UNH11.3%

    0.4 points apart

  • P/E

    TEVA–

    UNH20.0

  • Dividend yield

    TEVA0.0%

    UNH2.6%

    2.6 points apart

  • 5-year return

    TEVA+361.0%

    UNH-14.7%

    375.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TEVA+361.1%

UNH-14.7%

20040020222023202420252026
Returns by period
PeriodTEVAWith dividendsUNHWith dividends
1 year since November 17, 2025+71.7%Price +71.7%+12.1%Price +9.2%
3 years since November 17, 2023+366.6%+67.1% a yearPrice +366.6%-30.5%-11.4% a yearPrice -34.8%
5 years since November 17, 2021+361.0%+35.8% a yearPrice +361.0%-14.7%-3.1% a yearPrice -22.1%
10 years since November 18, 2016+14.2%+1.3% a yearPrice +9.5%+176.5%+10.7% a yearPrice +134.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TEVATeva Pharmaceutical IndustriesUNHUnitedHealth

Valuation

TEVAUNH
Valuation
Price$42.23$349.91
Market value$48.6B$318B
Enterprise value (EV)$65.3B$363B
P/E–20.0
P/E, 5-year median–25.0
P/B6.13.1
EV/EBIT45.515.2
Free cash flow yield2.6%7.2%

Results and growth

TEVAUNH
Results and growth
Revenue, 12 months$14.0B$450B
Net income, 12 months$507M$15.9B
Free cash flow, 12 months$1.2B$22.8B
Earnings per share, 12 months$0.43$17.52
Revenue growth, year on year4.3%11.8%
Revenue growth a year, past+0.7%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

TEVAUNH
Margins and returns on capital
Gross margin65.8%88.3%
Operating margin10.2%5.3%
Net margin3.6%3.5%
ROIC10.9%11.3%
ROE6.5%15.5%

Balance sheet

TEVAUNH
Balance sheet
Cash$4.1B$28.5B
Total debt$21.1B$74.3B
Net debt / EBITDA6.91.6
Interest cover1.6×6.2×

Dividends and buybacks

TEVAUNH
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TEVA or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Teva Pharmaceutical Industries or UnitedHealth?

By market value, UnitedHealth ($318B) is about 6.5 times Teva Pharmaceutical Industries ($48.6B), at today's prices.

How did TEVA and UNH stock do over the last 10 years?

Since November 18, 2016, TEVA's price moved +9.5% and UNH's +134.1%. With dividends: TEVA +14.2% (+1.3% a year), UNH +176.5% (+10.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, TEVA or UNH?

The dividend yield at today's price is none for Teva Pharmaceutical Industries and 2.59% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which has the higher profit margins, Teva Pharmaceutical Industries or UnitedHealth?

Over the last twelve months, the net margin was 3.6% for Teva Pharmaceutical Industries and 3.5% for UnitedHealth, and the operating margin 10.2% and 5.3%. Revenue was $14.0B and $450B.

Which is the better investment, Teva Pharmaceutical Industries or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.